cro.directory
← Compare landing

Chimera Biotec GmbH vs Eurofins Central Laboratory

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryChimera Biotec GmbHEurofins Central Laboratory
SummaryChimera Biotec provides ultra-sensitive GLP/GCP bioanalytical immunoassay support for drug development, including custom assay development, assay transfer, and method validation. Its proprietary Imperacer immuno-PCR technology supports sub-pg/ml sensitivity.Global network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.
Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Analytical Method Development & Validation
  • Bioanalysis
  • Phase I Clinical Trials
  • Central Laboratory Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Genomics & Sequencing Services
Modalities
  • Biologics (Other)
Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Phases
  • Discovery
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Discovery
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
LocationsData not yet provided.
  • Headquarters
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Chimera Biotec GmbH alternatives · Eurofins Central Laboratory alternatives

Markdown mirror: /compare/chimera-biotec/eurofins.md